Filters
Hikma launches Indomethacin Suppositories in the US
Press Release, Product 20 December 2024
New
Hikma acquires the rights to a portfolio of Takeda brands for the MENA region
Press Release, Product 19 December 2024
New
Hikma and Richter announce FDA submission acceptance for Denosumab biosimilar products
Press Release, Product 12 December 2024
New
Hikma launches Furosemide Injection, USP, in the US
Press Release, Product 09 December 2024
Sell-side analysts and investors visit Hikma Casablanca site
Press Release, Corporate 14 November 2024
New
Celebrating Global Biosimilars Week: Hikma champions access to essential medicines for patients in the MENA region
Story, Business Development 12 November 2024
New
Hikma continues strong strategic execution and reiterates guidance
Press Release, Financial Results 07 November 2024
New
Hikma's leadership receives prestigious recognitions in 2024
Story, Leadership 22 October 2024
Empowering lives - Hikma’s regional blood donation drives across MENA
Story, Responsibility 21 October 2024
New
Hikma celebrates 40 years of Hatch-Waxman drug savings
Insight, Corporate 30 September 2024
New
Hikma: where our purpose inspires our people
Insight, Corporate 23 September 2024
New
Hikma launches Foscarnet Sodium Injection, in the US
Press Release, Product 23 September 2024
Hikma completes Xellia acquisition
Press Release, Corporate 10 September 2024
Hikma launches Clindamycin in 5% Dextrose Injection in the US
Press Release, Product 03 September 2024
New
Bringing Better Health Within Reach: Improving access to medicine as the partner of choice in MENA
Insight, Corporate 28 August 2024
You have viewed 15 of 453 results